Minimal Residual Disease in Acute Lymphoblastic Leukemia
1 Ansichten
• 06/15/23
0
0
Einbetten
administrator
Abonnenten
The panelists, Raoul Tibes, MD, PhD; Stefan Faderl, MD; and Bijal D. Shah, MD, outline methods of measuring minimal residual disease and its role in the management of acute lymphoblastic leukemia.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare